{"filings":[{"id":106316,"accession_number":"0001640334-26-000053","cik":1622996,"company_name":"ACRO BIOMEDICAL CO., LTD.","ticker":"ACBM","form_type":"8-K","filed_at":"2026-01-08T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Acro Biomedical dismisses auditor KCCW, engages Weinberg & Company","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed KCCW Accountancy Corp. as independent auditor on January 4, 2026; no disagreements on accounting principles.","Engaged Weinberg & Company as new independent registered public accounting firm effective same date.","KCCW's audit reports for FY2024 and FY2023 contained an explanatory paragraph about going concern uncertainty.","No consultations with Weinberg on accounting principles or reportable events prior to engagement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1560000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":139337,"accession_number":"0001640334-25-001486","cik":1622996,"company_name":"ACRO BIOMEDICAL CO., LTD.","ticker":"ACBM","form_type":"8-K","filed_at":"2025-08-14T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"ACRO Biomedical appoints Yu-Ting Su as CEO and chairman; Pao-Chi Chu resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Pao-Chi Chu resigned as director, chairman and CEO effective upon successor's appointment; resignation not due to any disagreement.","Board appointed Yu-Ting Su as director, chairman and CEO effective August 14, 2025.","Ms. Su previously served as VP of cell banking division at BioSpring Co., Ltd. (Jan 2023 - Aug 2025) and VP at BioSeed Co., Ltd. (Aug 2020 - Dec 2022)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1560000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":139336,"accession_number":"0001640334-25-001097","cik":1622996,"company_name":"ACRO BIOMEDICAL CO., LTD.","ticker":"ACBM","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Acro Biomedical dismisses Prager Metis as auditor, engages KCCW","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Dismissed Prager Metis CPAs as independent auditor effective June 30, 2025; no disagreements reported for 2024, 2023, or interim 2025.","Prager Metis did not audit 2024 or 2023 financials; its 2022 audit report included a going-concern explanatory paragraph.","Board approved engagement of KCCW Accountancy Corp. as new independent accounting firm on June 30, 2025.","No prior consultations with KCCW on accounting principles, transactions, or audit opinions before engagement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1560000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}